Dr Todd Pinter, MD | |
233 Main St, New Britain, CT 06051-4204 | |
(860) 826-1358 | |
(860) 229-8886 |
Full Name | Dr Todd Pinter |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 43 Years |
Location | 233 Main St, New Britain, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174657365 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | 024866 (Connecticut) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Community Mental Health Affiliates Inc | 3375431968 | 31 |
News Archive
Transgene SA, a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases, announced pre-clinical data obtained with its novel immunotherapeutic, TG1050, to treat chronic hepatitis B infection.
The Minneapolis Heart Institute Foundation, Minneapolis Heart Institute at Abbott Northwestern Hospital, Mayo Clinic, and University of Minnesota are convening The Women and Heart Disease Summit in Minneapolis.
For the study, 170 patients with suspected coronary artery disease underwent CT-CA. The average vascular attenuation measured in the aortic root and in coronary arteries was used to divide the population into two groups of 85 patients each, one with low attenuations and one with high.
Epigem, a high-tech British micro engineering company, has issued a blood challenge to students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces).
Duke Health researchers have identified a drug-like small molecule that, in animal experiments, appears to be an effective treatment for a genetic disorder called Prader-Willi syndrome.
› Verified 7 days ago
Entity Name | Community Mental Health Affiliates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174624423 PECOS PAC ID: 3375431968 Enrollment ID: O20040305000722 |
News Archive
Transgene SA, a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases, announced pre-clinical data obtained with its novel immunotherapeutic, TG1050, to treat chronic hepatitis B infection.
The Minneapolis Heart Institute Foundation, Minneapolis Heart Institute at Abbott Northwestern Hospital, Mayo Clinic, and University of Minnesota are convening The Women and Heart Disease Summit in Minneapolis.
For the study, 170 patients with suspected coronary artery disease underwent CT-CA. The average vascular attenuation measured in the aortic root and in coronary arteries was used to divide the population into two groups of 85 patients each, one with low attenuations and one with high.
Epigem, a high-tech British micro engineering company, has issued a blood challenge to students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces).
Duke Health researchers have identified a drug-like small molecule that, in animal experiments, appears to be an effective treatment for a genetic disorder called Prader-Willi syndrome.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Todd Pinter, MD 233 Main St, New Britain, CT 06051-4204 Ph: (860) 826-1358 | Dr Todd Pinter, MD 233 Main St, New Britain, CT 06051-4204 Ph: (860) 826-1358 |
News Archive
Transgene SA, a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases, announced pre-clinical data obtained with its novel immunotherapeutic, TG1050, to treat chronic hepatitis B infection.
The Minneapolis Heart Institute Foundation, Minneapolis Heart Institute at Abbott Northwestern Hospital, Mayo Clinic, and University of Minnesota are convening The Women and Heart Disease Summit in Minneapolis.
For the study, 170 patients with suspected coronary artery disease underwent CT-CA. The average vascular attenuation measured in the aortic root and in coronary arteries was used to divide the population into two groups of 85 patients each, one with low attenuations and one with high.
Epigem, a high-tech British micro engineering company, has issued a blood challenge to students from the Durham University-led SOFI CDT (Centre for Doctoral Training in Soft Matter and Functional Interfaces).
Duke Health researchers have identified a drug-like small molecule that, in animal experiments, appears to be an effective treatment for a genetic disorder called Prader-Willi syndrome.
› Verified 7 days ago
Sheila Santhappa, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 608-224-5305 | |
Dr. Michael Balkunas, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, Ondrea Chasse, Medical Staff Office, New Britain, CT 06052 Phone: 860-224-5305 | |
Kevin J Felice, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2150 Corbin Ave, New Britain, CT 06053 Phone: 860-827-4924 | |
Dr. Marc Kawalick, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 35 Pearl St, New Britain, CT 06051 Phone: 860-223-3810 | |
Dr. Barry Spass, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 35 Pearl St, New Britain, CT 06051 Phone: 860-223-3810 | |
Dr. Patricia Aguayo, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2150 Corbin Ave, New Britain, CT 06053 Phone: 860-612-6386 |